Exuberant tumor-like synovial cell proliferation with invasion of periarticular bone is a feature of rheumatoid arthritis in humans and of streptococcal cell wall (SCW)-induced arthritis in rats. These histologic observations prompted us to examine synoviocytes from arthritic joints for phenotypic characteristics of transformed cells. The capacity to grow in vitro under anchorage-independent conditions is a characteristic that correlates closely with potential in vivo tumorigenicity. In medium supplemented with 20% serum or in basal media supplemented with platelet-derived growth factor (PDGF), early passage synoviocytes from both SCW-induced and rheumatoid arthritic joints formed colonies in soft agarose. Epidermal growth factor (EGF), interleukin 1 (IL-1), tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma), and transforming growth factor-beta (TGF-beta) did not support growth, although EGF enhanced PDGF-dependent growth. On the other hand, TGF-beta, as well as all-trans-retinoic acid, inhibited colony growth. Early passage normal rat and human synoviocytes also grew under the same conditions, but lung, skin, and late-gestation embryonic fibroblast-like cells did not. Considered in the context of other published data, our findings provide cogent evidence that synoviocytes, but not other types of fibroblast-like cells, readily acquire phenotypic characteristics commonly associated with transformed cells. Expression of the transformed phenotype in the inflammatory site is likely regulated by paracrine growth factors, such as PDGF and TGF-beta.
Introduction
An arthritic process that mimics many features of rheumatoid arthritis develops in female LEW/N rats after a single intraperitoneal injection of cell wall fragments (peptidoglycanpolysaccharide) from group A streptococci (SCW)' and several other bacteria (1) . This animal model is characterized by an acute inflammatory phase that begins 2-3 d after injection and is clinically apparent for 1-2 wk. This phase appears to be complement dependent (2) . It overlaps a chronic phase that becomes clinically apparent 2-6 wk after injection and results in proliferative and invasive destruction of the involved joints (1, 3) . This phase appears to be thymic dependent since it does not develop in athymic nude LEW.rnu/rnu rats (1, 4) , but does develop in athymic nude rats reconstituted with T cells (5) .
Moreover, it is markedly inhibited by treatment with cyclosporin A (6) . Histologic examination of synovium during the chronic phase of the disease reveals marked hyperplasia of the spindle-shaped synovial cell population. Reminiscent of transformed cells, these cells are frequently characterized by large pale nuclei, prominent nucleoli, and invasion of periarticular bone (7) . Mechanisms regulating this tumorlike synovial cell proliferation and invasion of bone are poorly understood.
Rheumatoid arthritis is similarly characterized by pronounced tumorlike expansion of the synovium primarily because of exuberant proliferation of synoviocytes (8, 9) . Histologically, this proliferating tissue has many of the characteristics of a neoplasm. Transformed-appearing synovial cells with large pale nuclei and prominent nucleoli are abundant, particularly at sites of synovial invasion/erosion of surrounding periarticular bone. Although the disease process is commonly associated with intense synovial mononuclear cell infiltration, the mechanisms driving the massive tumorlike growth and invasive behavior of the fibroblast-like synovial cells are not understood.
The extent to which rheumatoid and SCW arthritic synoviocytes actually express phenotypic characteristics associated with cell transformation has not been fully investigated. Abnormal and variable cell morphology, and cell growth beyond a monolayer resulting in high saturation densities are generally correlated with transformed cell growth; however, the best in vitro assay of cell transformation is anchorage-independent growth of cells in soft agar or agarose (10) (11) (12) (13) . Anchorage-independent growth of cells and cell lines is closely associated with transformation and is highly correlated, particularly for cells of mesenchymal origin, with in vivo tumor growth in nude mice (11, 13) .
We have recently reported that freshly explanted and early passage synovial fibroblast-like cells from rats with SCW-induced arthritis grow beyond a monolayer, form foci under anchorage-dependent conditions and grow under anchorageindependent conditions (7) . In the present study, we have demonstrated that fresh explant and early passage synovial fibroblast-like cells (synoviocytes) from patients with rheumatoid arthritis, as well as LEW/N female rats with SCW-induced arthritis, also, express phenotypic characteristics generally associated with transformed cells. In contrast to late passage cells or early passage cells treated with retinoic acid, early passage synoviocytes from both arthritic rats and humans grow to high saturation densities, form foci, and are able to grow under anchorage-independent conditions. Moreover, we have analyzed the effects of several cytokines and growth factors known to be present in the inflammatory extracellular fluid of the rheumatoid joint on anchorage-independent growth of rat and human synovial cells. We show that for both rat and human synovial cells platelet-derived growth factor (PDGF), but not interleukin 1 (IL-1), tumor necrosis factor-alpha (TNF-alpha), transforming growth factor-beta (TGF-beta), epidermal growth factor (EGF), or interferon-gamma (IFN-gamma), is a potent stimulator of anchorage-independent synoviocyte growth. Further, we show that TGF-beta partially inhibits growth. Of further significance, we show that nonrheumatoid human and normal rat synoviocytes also grow under anchorage-independent conditions, but, in sharp contrast, lung, dermal, and late-gestation embryonic fibroblasts and late-passage synoviocytes fail to form colonies under the same conditions.
Methods
Reagents and cytokines. Mouse EGF, human platelet PDGF, insulin, ITS+ 100X (insulin 0.625 mg/ml, transferrin 0.625 mg/ml, selenium 0.625 mg/ml, BSA 0.125 g/ml, and linoleic acid 0.535 mg/ml) and goat IgG anti-human PDGF were purchased from Collaborative Research, Inc., Bedford, MA. Recombinant human TNF-alpha, and recombinant rat and human IFN-gamma were purchased from Amgen Biologicals, Thousand Oaks, CA. Recombinant human IL-I alpha and beta were obtained from Genzyme Corporation, Boston, MA. Goat IgG was purchased from Jackson Immunoresearch Laboratories, Inc., West Grove, PA. The purification of TGF-beta has been previously described ( 14) . All-trans-retinoic acid (Sigma Chemical Co., St. Louis, MO) Synovial cell isolation. Synovial tissues were dissected from the joints of 100-1 50-g normal LEW/N female rats and from LEW/N female rats with SCW-induced arthritis. SCW-arthritis was induced by intraperitoneal injection of an aqueous solution of cell wall fragments as previously described in detail (15) . Normal synovium, lung, and dermal tissues were obtained from normal LEW/N female rats. In all cases, the tissue (-1 g) was minced and digested in collagenase (4 mg/ml type III; Worthington Biochemical Corp., Freehold, NJ) in Dulbecco's modified Eagle's medium (DME) at 37°C for 4-5 h. After digestion, the dissociated cells were collected by centrifugation at 500 g for 10 min, resuspended in complete medium (DME supplemented with penicillin 100 U/ml, streptomycin 100,ug/ml, and 10% FBS). The cell suspension was then cultured in a six-well cluster dish (35- [14] [15] [16] [17] gestation LEW/N rats. Limb buds were dissected from whole embryos, rinsed in PBS, minced, and digested in 0.25% trypsin, 0.02% EDTA for 10 min at 370C. After digestion, the cells were pelleted by centrifugation, resuspended in complete medium, and grown to confluence before assay of their anchorage-independent growth potential. Synovial tissues from patients with rheumatoid arthritis were obtained by arthroscopic biopsy in accordance with a research protocol approved by a research subpanel of the National Institutes of Health. Synovial tissues were also obtained by biopsy from the infrapatellar region of patients requiring arthroscopic surgery for joint trauma. In addition, osteoarthritic synovial tissue was obtained from patients undergoing joint replacement. These tissues were processed and cultured in the same manner as the rat tissues with the exception that the initial tissue explants were cultured in a slightly different culture media. Preliminary experiments using different basal media (DME vs. CMRL Medium 1066), with various combinations of human vs. FBS showed that cell growth and viability was optimal in DME supplemented with penicillin 100 U/ml, streptomycin 100 ,g/ml, glutamine 2 mM, 10% FBS, and 10% HS. This complete medium was used for propagation of all human cell cultures.
Assays ofsaturation density. The saturation density of human synoviocytes was determined by culture of first passage, late passage, and all trans retinoic acid (10-6 M) treated first passage synoviocytes from patients with rheumatoid arthritis. Cells were plated into 96-well plates at 1,000 cells/well and cultured in complete medium (containing 10% FBS and 10% HS). Every 2 d the cells from two wells were washed with PBS, trypsinized 15 min at 370C, and counted using a hemacytometer. The experiments were continued until cell growth had plateaued.
Assays of anchorage-independent cell growth. Agarose (Seaplaque agarose; FMC Corp., Rockland, ME) solutions (1% and 1.6%) were prepared in distilled water and autoclaved. DME (1 .67X) was prepared by dissolving premixed lX DME salts plus sodium bicarbonate (Sigma Chemical Co.) in 0.6 vol of distilled water. Typically, sufficient DME salts for 1 liter were dissolved in 550 ml distilled water; 49.3 grams sodium bicarbonate were added; the pH was adjusted to 7.2; the final volume was adjusted to 600 ml with distilled water; and the solution filter sterilized.
Soft agarose growth assays were carried out in 24-well cluster dishes. Wells were first coated with 0.5 ml mixture containing 0.64% agarose in basal media supplemented with serum at the desired concentration for the particular growth assay. For example, in experiments carried out in 20% FBS, this solution was prepared by mixing S ml FBS, 10 ml 1.67X DME and 10 ml 1.6% agarose, all preheated to 40°C before mixing and coating the wells. The agarose was allowed to solidify at room temperature. Next, the agarose layers that contained cells were prepared. These mixtures were prepared in the wells of a separate 24-well cluster dish and then transferred to the precoated wells, i.e., each well representing a different experiment. First, 1.67X DME plus serum was added to each well to give a final volume of 1.2 ml. The volume of serum added was determined by the desired serum concentration in a volume of 2 ml, i.e., the final volume of the cell containing agarose layer. The growth factor(s) or reagent to be tested was then added, and the concentrated media mixtures were allowed to equilibrate at 37°C in an incubator. While the media mixtures were equilibrating, the cells to be used in the assay were harvested by trypsinization, pelleted and resuspended in DME containing 10% FBS at the desired concentration, usually 106 cells/ml. These cells were passed through a 25-gauge needle to remove clumps and produce a single cell suspension. 10 Ad of the cell suspension were then added to each ofthe wells of warmed media mixtures. Next, 0.8 ml of 1% agarose, prewarmed to 40'C, were added to each well, and this mixture was then layered onto the previously prepared dishes coated with 0.64% agarose. The final concentration of agarose in the upper cell-containing soft agarose layer was, therefore, 0.4%; the concentration of cells was optimally 104 cells/well or 5 X 103 cells/ml.
Analysis ofanchorage-independent colony growth. To reproducibly quantitate colony growth in soft agarose, analysis was carried out using an image analyzer (model 982B; Artek Systems Corp., subsidiary of Dynatech Corp., Farmingdale, NY) interfaced to an IBM PC/XT computer, using software provided by the supplier. Counting was carried out through an inverted microscope with total magnification of 40. The analyzer was used in two programmed modes. The first mode measured colony size and number; using this mode, only colonies of 60 Jim diam or greater were counted. The second mode of operation allowed for a finer discrimination of colony growth by measuring the area of all the colonies imaged in the analyzed field and then calculating fraction of this area in the total imaged field. This mode of operation was used for analysis of experiments in which growth factors were added to serum containing medium, which supported colony growth even without additional growth factors. In these cases the total colony number generally changed less dramatically than did the size of the colonies. Measurement of the colony area allowed for a greater discrimination of changes under various conditions.
Results
Early passage adherent synovial cellsfrom both human and rat arthritic joints form foci and grow to high saturation densities under anchorage-dependent conditions. As previously described for synoviocytes from rats with SCW-induced arthritis (7), early passage human synovial cells from patients with rheumatoid arthritis upon prolonged culture grew beyond a monolayer and formed foci ( Fig. 1 A) . Late passage rheumatoid synoviocytes or rheumatoid synoviocytes treated with alltrans-retinoic acid (10-6 M), on the other hand, did not grow beyond a monolayer ( Fig. 1 , B and C). These morphologic features are consistent with a transformed phenotype in both human and rat early passage cells that was lost upon culture or treatment with retinoic acid. Also compatible with these observations, early passage rheumatoid synoviocytes (n = 1) grew to higher saturation densities than later passage cells (n = 16) or early passage cells treated with retinoic acid (10-6 M) (Table I).
Early passage synovial cells from both human and rat arthritic joints grow under anchorage-independent conditions in serum or PDGF-supplemented medium. Initially, we studied the growth of primary explant and early passage, adherent synovial cells from rats with SCW-induced arthritis for growth under anchorage-independent conditions as previously described (7). These cells grew under anchorage-independent conditions in the presence of 20% FBS (Fig. 2 A) . Colony growth declined at cell densities greater than 105 cells/ml, low serum concentrations and repeated cell passage (n > 3) (Fig. 2 B) .
Similarly, using conditions that support anchorage-independent growth of many human transformed cell lines (i.e., a medium of DME supplemented with 10% FBS and 10% HS), we found that primary explant, adherent rheumatoid synovial cells grew under anchorage-independent conditions (Fig. 2 C) . Colony growth declined at lower serum concentrations and was negligible in medium supplemented with only 1% FBS and 1% HS (Fig. 2 D) . Optimal cell concentration was 104 cells/ml. It is of interest that colony growth declined at cell densities of 105 cells/ml or greater. First and second passage synoviocytes also readily formed colonies, but by the third or fourth cell passage, the synoviocytes began to lose their capacity to grow under anchorage-independent conditions. The striking serum dependence of colony growth for synoviocytes from both rat and human arthritic joints and the known presence of certain cytokines in serum and rheumatoid synovial fluid led us to examine the effects of various cytokines on the anchorage-independent growth. Previous work has demonstrated PDGF, EGF, and insulinlike growth factors in serum (16, 17) , and rheumatoid synovial fluids are known to contain IL-i (18, 19) , TNF-alpha (20) , IFN-gamma (21, 22), EGF (23), PDGF, and TGF-beta (24). Therefore, the effects of these cytokines on anchorage-independent synoviocyte growth were analyzed. The initial set of experiments was performed on synoviocytes from arthritic rats. PDGF enhanced colony growth (10-50 ng/ml), and TGF-beta (0.025-25 ng/ml) partially inhibited it (50% maximal inhibitory concentration -5 X 10-12 M; Figs. 3 A and 4 A). IL-I (1-1,000 U/ml), TNFalpha (2-200 U/ml), gamma-IFN (1-1,000 U/ml) and EGF (1-50 ng/ml) did not have any or had only minimal effects over the range of concentrations tested (Fig. 3 A) . Similar experiments were carried out on synoviocytes from rheumatoid joints in the presence of 10% FBS/10% HS with and without these cytokines (Fig. 3 B) . PDGF (10-50 ng/ml) in a dose-dependent manner, markedly enhanced colony growth. TGFbeta (0.125-25 ng/ml) had a partial inhibitory effect, with a 50% maximal inhibitory concentration of -5 X 10" M (Figs. 3 A and 4 A) . IL-I (1-1,000 U/ml), TNF-alpha (2-200 U/ml), EGF (1-50 ng/ml), and IFN-gamma (1-1,000 U/ml) had neither statistically significant stimulatory nor inhibitory effects. IL-i was also tested in the presence of indomethacin (2.5 X 10-6 M), and again there was no apparent effect on either the human or rat cells (Figs. 3 A and B ). Further confirming the importance of PDGF, neutralizing anti-PDGF antibody (10 jg/ml), but not control antibody (10 ,ug/ml), completely blocked serum-stimulated colony growth of both rat and human synoviocytes (data not shown).
Having established the effects of these various growth factors as additives to medium containing 20% serum, we next studied their effects on primary explant and early passage synoviocytes from rat joints that were grown under low serum conditions (1% FBS) in medium supplemented with insulin, transferrin, selenium, albumin, and linoleic acid (ITS+ 5X). PDGF (10-50 ng/ml) stimulated colony growth in a dose-dependent manner; however, minimal colony growth was observed at 10 ng/ml or less. EGF (1-50 ng/ml) had no or weak effects at all concentrations tested (Fig. 5 A) . None of the other cytokines, over a wide range of concentrations, promoted any significant colony growth. EGF consistently augmented the growth stimulating effects of PDGF. TGF-beta (2.5 ng/ml) had no significant effect on PDGF-stimulated colony growth. Combinations of TGF-beta and EGF produced colony growth no greater than EGF alone.
Results similar to those of rat synoviocytes grown under low serum were observed with synovial cells from rheumatoid joints (Fig. 5 B) . In the presence of 1% FBS/1% HS alone, colony formation was negligible; however, the addition of PDGF stimulated significant colony formation at 50 ng/ml, but not at lower concentrations. EGF (1-50 ng/ml) had no effect alone, while EGF enhanced PDGF-stimulated colony growth. TGF-beta (0.25-25 ng/ml) did not stimulate alone or in combination with EGF, but partially inhibited PDGF-stimulated colony growth (maximal effect at 2.5 ng/ml). IL-I (1-1,000 U/ml), IL-I with indomethacin (2.5 X 10-6 M), TNF-alpha (2-200 U/ml), and IFN-gamma (1-1,000 U/ml) did not stimulate colony growth.
By contrast, and consistent with previously published data (25, 26), NRK cells exhibited exuberant colony formation in the presence ofa combination ofEGF (5 ng/ml) and TGF-beta (2.5 ng/ml) or high concentrations of PDGF (50 ng/ml) alone, but not with TGF-beta, EGF, or lower concentrations of PDGF (5 ng/ml) alone (data not shown). Cj&O. Inhibition of anchorage-independent synovial cell growth by retinoids. Since retinoids are known to (a) induce differentiation of many cell types (27) , (b) inhibit anchorage-independent growth of many neoplastic cell lines (28), (c) induce slow, contact-inhibited growth of SCW-arthritic derived synoviocytes (7) and (d) markedly inhibit SCW-induced arthritis in LEW/N rats in vivo (29), we examined their effects on the anchorage-independent growth of both human and rat synovial cells (Fig. 6, A and B) . As shown, all-trans-retinoic acid almost completely inhibited colony growth of both rat and human arthritic synovial cells at concentrations of 10-6 M or greater (50% maximal inhibition was observed between 10-8 and 10-9 M retinoic acid). These observations are additional evidence supporting our view that synoviocyte anchorage-independent growth reflects the acquisition of molecular and cellular characteristics associated with the transformed phenotype. Retinoids inhibit the expression of this phenotype.
Normal synoviocytes alsoform colonies when grown under anchorage-independent conditions. To judge the significance of anchorage-independent growth of synovial cells from human and rat arthritic joints, we also analyzed other cell types and cell lines for anchorage-independent growth in medium supplemented with 20% FBS. As expected, the transformed cell lines, HeLa 
Discussion
We, as well as others, have become increasingly impressed with the similarities between invasive tumors and the proliferative and invasive lesion characteristic of rheumatoid arthritis (8, 9, (30) (31) (32) (33) (34) . Mitoses are frequent in both. The major proliferating cell in situ is spindle shaped and is characterized by large pale nuclei with prominent nucleoli, reminiscent of tumor cells. Moreover, these "fibroblastoid" cells are the predominant cell type at sites of bone erosions (35) . They are often in close proximity to macrophages and proliferating blood vessels. We have pursued the hypothesis that a possible mechanism driving this tumorlike expansion and invasive behavior of synovial cells is that locally secreted paracrine growth factors, derived from infiltrating macrophages and lymphocytes as well as from endothelial and other cells, induce synovial cells to exhibit phenotypic characteristics in common with transformed cells, resulting in a locally proliferative and invasive inflammatory lesion. Thus, the rheumatoid lesion resembles a locally invasive tumor.
We have also been impressed that tumorlike synovial growth and local invasion of bone and cartilage, closely resembling rheumatoid arthritis, can be induced in genetically predisposed rats by systemic injection of peptidoglycan-polysaccharide fragments from the cell walls of certain bacteria, e.g., group A streptococci. Like rheumatoid arthritis, the proliferative and invasive lesion is predominantly composed of spindle-shaped cells with numerous mitoses, large pale nuclei, and prominent nucleoli. They are, like rheumatoid arthritis, usually in close proximity to macrophages and proliferating blood vessels (7). These observations have led us to further examine the synovial cells for characteristics associated with neoplastic transformation.
High saturation density, growth beyond a monolayer, and anchorage-independent growth have been correlated with a transformed phenotype in vitro. Anchorage-independent growth of cells in vitro is one of the most specific criteria for assessing the cell's potential for expression of a transformed phenotype in vivo. It has been shown to be highly correlated with a cell's ability to form tumors in athymic nude mice. This in vitro assay has been utilized extensively to define several transforming growth factors (36) as well as mechanisms underlying neoplastic cell growth including cellular transformation by oncogenes.
We have previously demonstrated that under anchoragedependent conditions early passage synovial cells from rats with SCW-induced arthritis grow beyond a monolayer, form foci, and grow to a higher saturation density than do later passage cells or early passage cells treated with retinoic acid. In addition, we have shown early passage synoviocytes from rats with SCW-arthritis grow under anchorage-independent conditions (7) . In the present study, we further examined anchorage-independent growth of rat synovial cells and have extended our studies to synoviocytes from patients with rheumatoid arthritis. We have shown that under anchorage-dependent conditions early passage synoviocytes from patients with rheumatoid arthritis, grew beyond a monolayer and formed foci, grew to a higher saturation density, and grew under anchorage-independent conditions. In contrast to malignantly transformed cells, the synoviocytes from both species lost, upon repeated passage in culture, these phenotypic markers of transformation. Anchorage-independent growth of early passage cells required serum or medium supplemented with appropriate growth factors, suggesting that tumor-like growth in vivo is driven not by autocrine, but by paracrine growth factors produced as a result of the inflammatory process. The failure of the synoviocytes to form tumors in nude mice is consistent with this hypothesis.
Serum is known to contain at least three growth factors: insulin-like growth factors, PDGF, and EGF (16, 17) . We have shown previously that PDGF and EGF, but not IL-1, TNFalpha, IFN-gamma, or TGF-beta are both important in supporting anchorage-dependent growth of synoviocytes ( (38) , had no stimulatory effect on anchorage-independent growth of arthritic synovial cells even in the presence ofindomethacin, which was added to block prostaglandin E2 production. This contrasts with the results of others demonstrating enhanced anchoragedependent proliferation of synovial cells by IL-1 in the presence of serum plus indomethacin (39) . However, our own data indicate that IL-1 is only minimally mitogenic for synoviocytes under anchorage-dependent conditions in the absence of serum (37, Remmers, E. F., R. Lafyatis, D. E. Yocum, A. B.
Roberts, G. K. Kumkumian, J. P. Case, M. B. Sporn, and R. L. Wilder. Manuscript submitted for publication). TNFalpha, also, did not support anchorage-independent growth of synovial cells. Similar to IL-1, this cytokine stimulates production of prostaglandin E2 and collagenase by synovial cells (40) and has been shown to augment growth of some normal cell lines; however, it inhibits or has no effect on growth of tumor cell lines (41) . IFN-gamma has been reported to increase proliberation of rabbit synoviocytes grown under anchorage-dependent conditions and to induce Ia and inhibit collagen syn- thesis of human synoviocytes grown under anchorage-dependent conditions (42, 43) . This cytokine had no effects on the growth of either human or rat arthritic synovial cells in our studies. TGF-beta, initially isolated on the basis of its capacity to induce anchorage-independent, but not anchorage-dependent growth of NRK cells, has since been shown to have pleiotropic effects depending on the cell type examined (44) . On some cell types, it appears to stimulate differentiation. On dermal fibroblasts it increases secretion of collagen and when injected intradermally it causes fibrosis (45) . We have recently demonstrated physiologically significant levels of TGF-beta in rheumatoid synovial fluid (25-75 ng/ml) and have also immunolocalized TGF-beta diffusely throughout specimens of rheumatoid synovium, as well as synovium from rats with SCW arthritis (24). Our data presented here demonstrate that TGFbeta partially inhibited anchorage-independent growth of both human and rat synoviocytes. In view ofthe local production of this cytokine by proliferative synovium, our data suggest that TGF-beta may be involved in suppressing in vivo synovial cell proliferation and inducing a more differentiated phenotype, (i.e., slower growth, increased production of collagen, and decreased production of matrix-degrading enzymes), consistent with the more mature stages of wound repair.
The contrasting effects of PDGF, IL-1, TNF-alpha, EGF, TGF-beta, and IFN-gamma on synovial cells in vitro point out the complexity of the regulatory pathways involved in the tissue destruction characteristic of rheumatoid and SCW-in- An important distinction should be emphasized here between autocrine and paracrine growth factor-driven transformation of cells. The homology of some viral oncogenes to growth factors suggests that expression of the malignant phenotype in some virally transformed tumors is induced through dysregulated autocrine production of a growth factor (30, 52) . A similar mechanism of transformation is suggested for the U-2 osteosarcoma cell line in that this cell line produces PDGF and expresses PDGF receptors (53 Lastly, our observations on the effects of retinoids need comment. These agents, known to inhibit the anchorage-independent growth of several cell lines derived from malignant tumors, are shown here to inhibit anchorage-independent growth of synoviocytes and induce monolayer growth. Previous work in our laboratories has shown that treatment ofrats with retinoids before or after induction of SCW-induced arthritis significantly inhibits the disease (29). Histologically, synovial cell hyperplasia and synovial invasion of periarticular bone are inhibited and synovial fibrosis is induced. Production of prostaglandin E2 and collagenase, both potential mediators of tissue destruction, are markedly suppressed. In the experiments presented here, which are consistent with the known effects of retinoids in inducing differentiation, all-trans-retinoic acid completely inhibited anchorage-independent growth of both human and rat synoviocytes at concentrations achievable in vivo. Taken together these data suggest that inhibition of synovial cell transformation may be the primary mechanism by which retinoids suppress arthritis in vivo. If this is the case, suppression oftransformed synovial cell growth might be an effective therapeutic strategy in rheumatoid arthritis, and inhibition of soft agarose synovial cell growth might provide an in vitro assay system in the development of new therapeutic agents. Unfortunately, the actions of retinoids on many other cell types makes it impossible to definitively assign inhibition of synovial cell transformation as the primary target of this drug in vivo at this time.
In summary, our data, considered in the context of published data, provide further evidence supporting the view that synovial cells in rheumatoid and SCW-induced arthritis have acquired a cellular phenotype generally associated with invasive tumors. The acquisition of the abnormal phenotype in vivo is probably regulated as it is in vitro by paracrine growth factors such as PDGF and TGF-beta. It is likely that localized phenotypic transformation of synovial cells is a critical aspect of the tissue destruction characteristic in rheumatoid arthritis and the essentially identical destructive disease process observed in SCW-induced arthritis in LEW/N female rats. Our data indicate that synovial cells, in sharp contrast to several other fibroblast-like cells, are relatively unique in their susceptibility to exhibit properties generally associated with autonomously transformed cells. These data support the concept that even among fibroblastoid mesenchymal cells, the type and differentiation state of the target cell determines the biological effects of a given growth factor (or factors), i.e., the biologic response, even of "fibroblasts," is not necessarily an intrinsic property of the cytokine. We expect that further investigation of mechanisms underlying these observations will lead to new insights into the pathogenesis and therapy of rheumatoid arthritis, related arthritides, and probably other inflammatory diseases.
